Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| IM Develops AI-driven drug discovery and oncology treatments | $5M | StrategicUndisclosed | Biotech | United States | Investors | |
| B |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
Develops AI infrastructure to improve clinical trial design and execution
| $52M |
| Series A |
| Biotech, Healthtech |
| Spain |
| Investors |
| E EpikastCompany profile Provides technology-enabled commercial and clinical services for biopharmaceutical industry Provides technology-enabled commercial and clinical services for biopharmaceutical industry | Undisclosed | Undisclosed | Biotech | United States | Investors |
| TB Twogee BiotechCompany profile Develops customised enzyme solutions for converting biomass into sustainable raw materials Develops customised enzyme solutions for converting biomass into sustainable raw materials | €2.2M | Seed | Biotech, Climate tech | Germany | Investors |
| TT Develops treatments to rejuvenate vision in the aging eye | $235M | Series B | Biotech | United States | Investors |
| PC PranaX CorporationCompany profile Develops exosome-based technologies for regenerative biologics and wellness Develops exosome-based technologies for regenerative biologics and wellness | $17M | Series A | Biotech | United States | Investors Undisclosed |
| A Builds AI-ready lab automation platforms for life sciences | $45M | Series CSeries C+ | Biotech, Industrial tech | United Kingdom | Investors |
| P PrenosisCompany profile Develops integrated diagnostics and therapeutics for critical care conditions Develops integrated diagnostics and therapeutics for critical care conditions | $20M | Series A | Biotech | United States | Investors |
| ET Elysium TherapeuticsCompany profile Develops treatments to prevent and reverse overdoses caused by synthetic opioids Develops treatments to prevent and reverse overdoses caused by synthetic opioids | $7.5M | SAFEUndisclosed | Biotech | United States | Investors Undisclosed |
| HA Heritable AgricultureCompany profile Develops AI-driven crop improvement solutions for climate-resilient crops Develops AI-driven crop improvement solutions for climate-resilient crops | $5M | GrantUndisclosed | Biotech, Agritech | United States | Investors |